Fortune: Corporations break themselves up all the time. So why shouldn’t regulators break up Big Tech?

Anti-Monopoly Policies & Enforcement

August 25, 2022 — In Fortune, Economic Liberties' Senior Fellow Denise Hearn made it clear that corporate break ups are common and explained how they can benefit consumers, workers, small businesses, and even investors.

Why Merger Policy Matters

Anti-Monopoly Policies & Enforcement

August 23, 2022 — On the heels of a historic post-pandemic merger wave, and a recent joint Federal Trade Commission and Department of Justice merger guideline rewriting initiative, the American Economic Liberties Project released “Why Merger Policy Matters,” highlighting why the movement underway to rethink merger policy is key to leveling the playing field for businesses, consumers, and working people.

Morgan’s Monopoly Digest – August 2022

Anti-Monopoly Policies & EnforcementCompetition Policy Digest

August 10, 2022 — Economic Liberties' Director of Policy & Advocacy Morgan Harper launched a monthly newsletter to catalogue the latest with the “antitrust agencies,” the Federal Trade Commission (FTC) and the Department of Justice (DOJ), Antitrust Division, as well as cover the work of other federal agencies that regulate competition policy.

USA Today: Don’t let the airlines fool you. Regulate their cancellations and high fares.

Anti-Monopoly Policies & Enforcement

July 21, 2022 — In USA Today, Economic Liberties’ Senior Fellow for Aviation & Travel Bill McGee lays out the causes of the current airline and travel crisis, highlighting Secretary Buttigieg’s inadequate response and arguing for rolling back federal preemption, which currently prevents state attorneys general among others from holding the airlines accountable.

The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists

Anti-Monopoly Policies & EnforcementHealthcare

June 22, 2022 — Designed to catalogue the ways PBMs wield their power to exploit patients, pharmacists, doctors and our government, "The Pharmacy Benefit Mafia" details PBMs’ abusive business practices, their history of skirting regulation, and how the FTC’s recent efforts can put power back into the hands of patients and pharmacists.